SEC Comment Letter 0000000000-24-011948 to Xenetic Biosciences, Inc. (XBIO) (CIK 0001534525) (XBIO)
Xenetic Biosciences, Inc. (XBIO) (CIK 0001534525)
Date: Oct. 25, 2024 · CIK: 0001534525 · Accession: 0000000000-24-011948
AI Filing Summary & Sentiment
File numbers found in text: 333-282756
Letter
October 25, 2024 James F. Parslow Interim Chief Executive Officer and Chief Financial Officer Xenetic Biosciences, Inc. 945 Concord Street Framingham, Massachusetts 01701 Re:Xenetic Biosciences, Inc. Registration Statement on Form S-3 Filed October 21, 2024 File No. 333-282756 Dear James F. Parslow: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Danielle C. Price
Show Raw Text
October 25, 2024
James F. Parslow
Interim Chief Executive Officer and Chief Financial Officer
Xenetic Biosciences, Inc.
945 Concord Street
Framingham, Massachusetts 01701
Re:Xenetic Biosciences, Inc.
Registration Statement on Form S-3
Filed October 21, 2024
File No. 333-282756
Dear James F. Parslow:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Danielle C. Price